| Serial Number | 79250615 |
| Word Mark | LAMBDA-CAP |
| Filing Date | Monday, December 3, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 11, 2020 |
| Registration Number | 5980170 |
| Registration Date | Tuesday, February 11, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2019 |
| Goods and Services | Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases |
| Goods and Services | Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products |
| Goods and Services | Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 5, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 5, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 5, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Numab Therapeutics AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Numab Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Numab Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Wednesday, March 13, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 31, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, February 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, February 9, 2019 | APPLICATION FILING RECEIPT MAILED |
| Sunday, March 3, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, March 12, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 20, 2019 | REFUSAL PROCESSED BY MPU |
| Friday, September 20, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 20, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 5, 2019 | REFUSAL PROCESSED BY IB |
| Friday, June 21, 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, September 20, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, October 10, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 10, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 10, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, October 16, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, October 21, 2019 | ASSIGNED TO LIE |
| Wednesday, November 6, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 11, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 11, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, May 27, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, June 12, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, May 27, 2020 | FINAL DISPOSITION PROCESSED |
| Tuesday, February 11, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Sunday, December 31, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 20, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 27, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |